Debut Plus

₹21.12

▲ +0.22 +1.05%

17 Jul 2026

BSE Listed

Kabra Drugs Ltd. (524322)

Volume: 51,670Avg Vol 1W: 1,00,810Avg Vol 1M: 1,13,13852W Range:₹15.5₹35.52
BSE www.kabradrugs.com
Key Ratios
Checked just now
Market Cap₹50 Cr
Current Price₹21.12
Previous Close₹20.9
High / Low (52w)₹35.52 / ₹15.5
Volume51,670
Avg Vol (1W)1,00,810
Avg Vol (1M)1,13,138
Stock P/E10.11
Book Value₹12.49
Dividend Yield0%
ROE16.75%
ROA5.76%
Revenue (TTM)—
Revenue Growth—
Profit Margin5.36%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹2.09
P/B1.69
Debt / Equity0.08
50 DMA₹23.66
200 DMA₹25.69
Day change+1.05%
Price Chart
₹21.12▼ 0.98% · 1Y
₹35₹1319.2L
2025-07-17
2026-07-17

20-day avg volume: 1.1L shares

Pros
  • Healthy return on equity of 16.8%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹7 Cr₹20 Cr₹30 Cr₹35 Cr
EBITDA₹-1 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹2 Cr₹3 Cr₹1 Cr
Net Profit₹-1 Cr₹0 Cr₹-1 Cr₹0 Cr₹0 Cr₹2 Cr₹3 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EBITDA₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr
Net Profit₹-2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr
EPS-5.37-0.38-0.14-0.41-0.42-0.77-1.68-0.99
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹5 Cr₹25 Cr
Total Liabilities₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹3 Cr₹1 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹1 Cr₹25 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-5 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹23 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-5 Cr
Shareholding
Promoter 0% Institutions 0% Public 100%
Efficiency & Working Capital
ROCE19.1%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details

As of 2026-03-31

Promoter0%
FII0%
DII0%
Institutions0%
Public100%
Promoter Pledge—
No. of Shareholders9,185
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public100%100%100%100%100%100%100%100%100%100%100%100%
Promoter Pledge————————————
No. of Shareholders7,4207,4157,3967,3647,3367,3677,3437,4357,4498,0988,8629,185
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Veeramreddy Vijay Kumar Reddy .Public Shareholding3.3%7,80,336
Kuniamuthur Nanjappan AnandPublic Shareholding2.8%6,58,500
Priyam Samir ShahPublic Shareholding2.7%6,50,000
Somisetty Malathi LathaPublic Shareholding2.2%5,31,163
Giridhar Gupta SomisettyPublic Shareholding2.1%5,03,596
Chandraprakash Jamnalal KabraPublic Shareholding1.7%4,00,000
Priyam SachdevaPublic Shareholding1.4%3,24,183
Narendra Babu VeerlaPublic Shareholding1.3%2,98,930
Akilandeswari Selva MurthyPublic Shareholding1.2%2,91,816
Adusumilli Sai Raghava PratapPublic Shareholding1.2%2,72,727
Akansha GuptaPublic Shareholding1.1%2,52,437
Neha Sagar ShahPublic Shareholding1.1%2,50,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Veeramreddy Vijay Kumar Reddy .00%2026-03-31
Kuniamuthur Nanjappan Anand00%2026-03-31
Priyam Samir Shah00%2026-03-31
Somisetty Malathi Latha00%2026-03-31
Giridhar Gupta Somisetty00%2026-03-31
Chandraprakash Jamnalal Kabra00%2026-03-31
Priyam Sachdeva00%2026-03-31
Narendra Babu Veerla00%2026-03-31
Adusumilli Sai Raghava Pratap00%2026-03-31
Akansha Gupta00%2026-03-31
Neha Sagar Shah00%2026-03-31
Akilandeswari Selva Murthy00%2026-03-31
Board of Directors
NameDesignationYear
N AravindExecutive Director & MD2025
Venkatakrishnappa Ananth KumarExecutive Director / Whole Time Director / CFO2025
KUNIAMUTHUR NANJAPPAN ANANDExecutive Director2025
Ananthkumar ShilpaIndependent Director2025
A AnithaIndependent Director2025
Monika SanwalCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Drugs₹8 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10402424
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000000
2025000000
2025000000
Company Information
Incorporated1989
AuditorP P N AND COMPANY
Investor Email[email protected]
🌐 www.kabradrugs.com ↗

📍 270 Shastri Market Indore, Indore, Madhya Pradesh, 452007

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Pentokey Organy (India) LimitedWanburyResonance Specialties Ltd.Gujarat Inject Kerala LimitedAimco Pesticides Ltd.Gujarat Terce LaboratorieSeya IndustriesShree Hari Chemicals ExpoIndo Borax & ChemicalsVimta LabsBiofil ChemicalsIshita Drugs & IndustriesAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search